Long-term inhibition of the renin-angiotensin system in genetic hypertension
- 1 April 1997
- journal article
- review article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 15 (4) , 339-348
- https://doi.org/10.1097/00004872-199715040-00004
Abstract
To compare, using data from published studies, the efficacy of chronic inhibition of the renin-angiotensin system in inducing persistent downregulation of hemodynamic and cardiovascular structural changes in an adult rat with established genetic hypertension with the widely accepted known downregulation in young genetically hypertensive rats. We report on 36 studies that satisfied our inclusion criteria (angiotensin converting enzyme inhibitor or angiotensin II receptor antagonist treatment that lowered arterial pressure levels for at least 3 weeks). Of the 24 studies concerning developing hypertensive rats, a significant number (n = 17) also examined the persistence of any hemodynamic or cardiovascular effects after withdrawal of treatment. Conversely, of 15 studies using adult rats only seven and three reported on post-treatment hemodynamic and cardiovascular structural indices respectively. During treatment the hemodynamic and cardiovascular structural changes produced were qualitatively and quantitatively similar in the young and adult treated rats. Critical assessment of the persistence of these effects after withdrawal of treatment again found qualitatively similar responses. However, the strength of this finding is limited by the paucity of studies concerning adult rats in which equivalent treatment durations and equipressor doses of treatments were compared between these two age groups. Blockade of the renin-angiotensin system appears to have an efficacy in reversing established hypertension and hypertrophy similar to that with which it prevents the development of hypertension and hypertrophy. This partial 'cure' of hypertension after withdrawal of treatment is clearly evident when treatment is initiated during the development of hypertension and appears to be similar even when treatment is initiated in established hypertension.Keywords
This publication has 83 references indexed in Scilit:
- Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.Circulation, 1993
- Forearm arterial distensibility in patients with hypertension: Comparative effects of long-term ACE inhibition and β-blockingClinical Pharmacology & Therapeutics, 1993
- Role of Angiotensin-Converting Enzyme Inhibitors in Preventing or Reducing End-Organ Damage in HypertensionJournal of Cardiovascular Pharmacology, 1992
- Advances in the treatment of chronic heart failure.BMJ, 1992
- Reversal of Left Ventricular Hypertrophy in Hypertensive PatientsAmerican Journal of Hypertension, 1992
- Angiotensin-Converting Enzyme Inhibition and Vascular Structure in HypertensionJournal of Cardiovascular Pharmacology, 1991
- Differential structural responses of small resistance vessels to antihypertensive therapy.Circulation, 1987
- Lack of effect of anti-hypertensive treatment with felodipine on cardiovascular structure of young spontaneously hypertensive ratsCardiovascular Research, 1985
- Effects of Chronic Administration of Enalapril and Propranolol on the Large Arteries in Essential HypertensionJournal of Cardiovascular Pharmacology, 1985
- Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive ratsBritish Journal of Pharmacology, 1983